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Abstract
Background: Mumps virus is a negative-sense, single stranded RNA virus consisting of a ribonucleocapsid core
enveloped by a lipid membrane derived from host cell, which causes mumps disease preventable by vaccination.
Since virus lipid envelope and glycosylation pattern are not encoded by the virus but dependent on the host cell
at least to some extent, the aim of this work was to analyse L-Zagreb (L-Zg) mumps virus lipids and proteins
derived from two cell types; Vero and chicken embryo fibroblasts (CEF). Jeryl Lynn 5 (JL5) mumps strain lipids were
also analysed.
Methods: Virus lipids were isolated by organic phase extraction and subjected to 2D-high performance thin layer
chromatography followed by lipid extraction and identification by matrix-assisted laser desorption/ionization mass
spectrometry (MALDI MS). Virus samples were also subjected to gel electrophoresis under denaturating conditions
and protein bands were excised, in-gel trypsinized and identified by MS as well as tandem MS.
Results: Results showed that lipids of both mumps virus strains derived from Vero cells contained complex
glycolipids with up to five monosaccharide units whereas the lipid pattern of mumps virus derived from CEF was
less complex. Mumps virus was found to contain expected structural proteins with exception of fusion (F) protein
which was not detected but on the other hand, V protein was detected. Most interesting finding related to the
mumps proteins is the detection of several forms of nucleoprotein (NP), some of which appear to be C-terminally
truncated.
Conclusions: Differences found in lipid and protein content of mumps virus demonstrated the importance of
detailed biochemical characterization of mumps virus and the methodology described here could provide a means
for a more comprehensive quality control in vaccine production.
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Background
Mumps virus is a nonsegmented, negative stranded RNA
virus of the family Paramyxoviridae, subfamily Paramyx-
ovirinae, genus Rubulavirus that causes mumps disease.
Mumps virions are pleomorphic particles ranging from
100 to 800 nm in size [1], consisting of a helical ribonu-
cleocapsid core surrounded by a host cell-derived lipid
envelope. Full-length genomic RNA consisting of 15384
nucleotides contains 7 tandemly linked transcription
units that encode open reading frames for the nucleo-
protein (NP), phosphoprotein (P), V protein, I protein,
matrix (M) protein, fusion (F) protein, small hydropho-
bic (SH) protein, hemagglutinin-neuraminidase (HN)
protein, and the large (L) protein [2]. Due to the RNA
editing by insertion of G nucleotides, P gene results in
three mRNA transcripts corresponding to P, V and I pro-
teins [3]. Nucleoprotein packages RNA into a nucleocap-
sid that is used as a template for transcription and
genome replication by RNA polymerase which is com-
posed of L and P protein [4, 5]. V protein was found to
inhibit INF-β induced antiviral state [6–8]. SH protein is
considered to be a membrane protein [9] with possible
function in blocking TNF-α-mediated apoptosis pathway
* Correspondence: mbrgles@gmail.com
1University of Zagreb, Centre for Research and Knowledge Transfer in
Biotechnology, Rockefellerova 10, HR-10000 Zagreb, Croatia
2Center of Excellence for Viral Immunology and Vaccines, CERVirVac, Rijeka,
Zagreb, Croatia
Full list of author information is available at the end of the article
© 2016 Brgles et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Brgles et al. Virology Journal  (2016) 13:9 
DOI 10.1186/s12985-016-0463-0
[10]. On the virus surface are HN and F proteins that
are glycosylated by the host cell machinery. HN is an at-
tachment protein that binds receptor, and the role of F
protein is to drive fusion of virus and the cell membrane
resulting in virus entry [11]. Virus envelope is acquired
from the lipids of the host cell during budding process
and as well as protein glycosylation pattern, it is not
encoded directly by the virus. For paramyxoviruses, as
well as for many other viruses (retroviruses, alpha-
viruses, rabdoviruses, orthoviruses), it has been shown
that they bud predominantly from the surface of the in-
fected cells. However, virus budding can also occur from
intracellular membranes, e.g. human immunodeficiency
virus type-1 (HIV-1) [12, 13]. Lipid composition of sev-
eral viruses has been investigated so far such as HIV
[14–17], murine leukemia virus [17], influenza virus
[18], hepatitis C virus [19], Singapore grouper iridovirus
[20], semliki forest virus [21–23], and vesicular stoma-
titis virus [21, 24]. These investigations revealed in some
cases resemblance of the virus membrane to plasma
membrane of the host cell, but in some cases also sig-
nificant differences which have been described as a con-
sequence of virus budding from lipid rafts. So, whether
virus buds from a distinct membrane region and
whether this is to some extent virus directed still re-
mains an open question. Mumps virus proteins have
been investigated in 1970s and 1980s using technology
available at that time. Most of the mumps proteins were
tentatively detected, underwent limited characterization,
and were found to be similar to other paramyxoviruses
but were mostly not confirmed unambiguously [25–32].
Mass spectrometry (MS) is a powerful tool in the field
of biochemistry and is emerging as a core component of
fundamental discoveries also in the field of virology [33].
Combination of mass spectrometry and a relatively sim-
ple but efficient method high-performance thin layer
chromatography (HPTLC) has been shown as a very
convenient method for lipid analysis for not too complex
lipidomes [34, 35].
Virus proteome and lipidome are expressed virus fea-
tures that to some extent depend on the host cell and
these must have an impact on virus characteristics such
as infectivity and stability. Considering live virus vac-
cines, these features possibly affect vaccine performance.
Therefore, methods characterizing both virus proteins
and lipids could be a tool in raising the level of viral vac-
cines quality control. The aim of this research was to
analyse lipid and protein pattern of the mumps virus de-
rived from two cell lines (Vero and chicken embryo fi-
broblasts (CEF)) by means of mass spectrometry.
Genome of L-Zagreb (L-Zg) mumps virus has been fully
characterized [36] and here we report results on L-Zg
mumps virus lipids and proteins for the first time in a
truly holistic approach. Obtained data indicate that lipid
profile of mumps virus depends on the host cell line and
interestingly viruses derived from Vero cells contain gly-
colipids with up to five monosaccharide units. Mumps
virus proteome was found to contain more than one




Investigation of the most abundant mumps virus pro-
teins was performed on L-Zg mumps virus grown on
two cell substrates, CEF and Vero cells. Purified mumps
virus was subjected to electrophoresis under denaturat-
ing conditions. Results show that proteins of mumps
virus derived from two cell types, CEF and Vero, are
similar (Figs. 1 and 2, respectively, Additional file 1:
Table S1). There are more host cell proteins detected in
samples derived from Vero cells but this is probably a
result of limitation of the applied purification and detec-
tion techniques. Disruption of the cell caused by virus
Fig. 1 SDS-PAGE of L-Zg mumps virus grown in CEF. Left line is under
non-reducing and right line under reducing conditions. Indicated on
the right side are the theoretical molecular masses of mumps virus
proteins. Proteins that have been identified by MS are marked on the
left side. Glycoproteins are marked with „ + ?” since the glycan mass
is unknown
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infection is variable, and is expected to have an impact
on the purity of the virus. Problem of the virus isolation
procedure and ability to clearly discern contaminating
from interacting or constituting host cell proteins in vi-
rions has been recognized as controversial [37]. Virus
purification procedure employed here consists of collect-
ing supernatant from cells with visible cytopathic effect
and removal of cell parts by low speed centrifugation
followed by pelleting of viruses by ultracentrifugation.
Analysis of ultracentrifugation purification procedure
was found to result in 10 % recovery (n = 23) of infectiv-
ity in the pellet (determined by 50 % cell culture infect-
ive dose assay) whereas amount of the infective virus in
the supernatant was below 0.01 % (manuscript in prep-
aration). Low speed centrifugation step may not be fully
effective in removal of cell proteins that are incorporated
in the small parts of the cellular membrane generated
during cytophatic effect caused by the viral infection of
the cell, resulting in their copurification with virus parti-
cles during ultracentrifugation. Unfortunately, copurifi-
cation of parts of cellular membranes with virions
cannot be avoided even by density gradient purification
due to the possibility of similar sedimentation coeffi-
cient. However, host cell proteins can be incorporated
into virions simply by being fortuitously present at the
site of budding or preferentially incorporated into vi-
rions thereby influencing viral biology and pathogenesis
[38] and host cell proteins in virions have been reported
for various viruses [37–44]. During our work, several
virus preparations were purified and found to vary re-
garding amount of cell proteins. Host cell proteins that
were detected are fibronectin, clathrin, actin, histones,
heat shock proteins (HSP), annexins, tubulin, ribosomal
protein, myosin, and all these proteins were reported to
be detected in other viruses also [37–44]. Some early pa-
pers on sucrose gradient purified mumps virus particles
report that mumps virions contain actin [25, 28, 29]. For
respiratory syncytial virus, also a paramyxovirus, associ-
ation with HSP70, HSP90 and actin among other host
cell proteins has been reported [44]. Role of actin in
virus morphogenesis of several viruses is described [45]
as well as its role in respiratory syncytial virus matur-
ation [46] therefore similar function could be expected
in mumps.
Out of nine proteins coded by seven mumps genes,
only four, HN, NP, M and P, were identified in mumps
virus grown in CEF, whereas in mumps virus grown in
Vero, additionally L and V proteins were detected (iden-
tification data are listed in Additional file 1: Table S1).
HN protein was detected in two and NP in three bands.
Proteins not detected and identified in any of our
tested samples in purified virus preparations were F, SH
and I protein. I protein is not considered as a structural
protein so its presence in purified virus preparations is
not expected. SH protein was detected in virus infected
cells and is considered to be a membrane protein [9, 10]
but has not yet been detected in mumps virions. F pro-
tein is synthesized as a precursor molecule F0 that is
processed by host cell proteases to yield active F protein
composed of two disulphide-linked polypeptides [47].
Processing of the F protein has been well studied on cell
lysates and F protein was detected by immunoprecipita-
tion of the disrupted virus by anti-F antibodies [31] and
in case of radioactively labelled glycoproteins in purified
mumps virions [26]. However, by means of the tech-
niques applied here we could not detect the F protein so
far. Possible reasons for the lack of F protein detection
could be its very low expression level, glycosylation level
of the peptides (not covered by the applied MS method),
low extraction efficiency from the gel matrix or peptide
ion suppression, or the combination of all these factors.
Interestingly, unsuccessful detection of F protein was re-
ported for measles protein (also a member of Paramyxo-
viridae) and also multiple NP forms were confirmed
[48] same as found in our work on mumps virus.
In mumps virus derived from CEF, NP has been de-
tected in three bands and the band with the highest ap-
parent molecular mass is most intensive and
corresponds to theoretical (calculated from amino-acid
Fig. 2 SDS-PAGE (under reducing conditions) of L-Zg mumps virus
grown in Vero cells (two independent sample preparations). On the
left side are theoretical mumps proteins and their calculated masses.
Proteins that have been identified by MS are marked on the right
side. Glycoproteins are marked with „ + ?” since the glycan mass is
unknown. ni – not identified
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sequence) NP molecular mass around 61 kDa, whereas
the other two have lower molecular mass, around 55
and 48 kDa (Fig. 1). Peptide mass fingerprint (PMF)
spectra of all three NP forms were analysed (Fig. 3, full
peptide list in Additional file 1: Table S2) and it can be
seen that spectra of NP bands with lower apparent mo-
lecular masses are missing C-terminal peptides. The
same was found for mumps virus grown in Vero (Fig. 2).
Presence of two NP bands in Fig. 2(a), instead of three
as in Fig. 2(b) is presumably due to the limitation of the
CBB detection and the present sample amount. Again,
analysis of PMF was performed (Additional file 1: Figure
S1, Table S3) and the C-terminal tryptic peptide was
only present for the NP band of highest molecular mass,
the same as with the CEF sample. Additionally, in
Fig. 2(b) NP was also detected above 260 kDa marker
and this is most likely an aggregated form of NP. The
lowest of these protein bands, at 48 kDa, in addition to
A
B
Fig. 3 a Peptide mass fingerprint (based on positive ion MALDI reflectron MS) of NP forms (depicted in Fig. 1, reduced sample). Green (bottom)
mass spectrum – NP apparent molecular mass 48 kDa; blue (middle) mass spectrum – NP apparent molecular mass 55 kDa; red (top) mass
spectrum – NP apparent molecular mass 61 kDa. (full list of peptides with matching theoretical peptides is given in Additional file 1: Table S1).
b Sequence coverage of NP bands from Fig. 1. Red line – NP apparent molecular mass 61 kDa; blue line – NP apparent molecular mass 55 kDa;
green line – NP apparent molecular mass 48 kDa. Possibly modified amino acids are underlined
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NP contained also P protein peptides and this molecular
mass corresponds to the theoretical mass of P protein of
42 kDa. It should be stressed that a peptide’s occurrence
in mass spectra can be influenced by various factors;
trypsinization efficiency, selectivity during peptide isola-
tion, MS inherent difficulties like ion suppression by
presence of other peptides and selective desorption/
ionization [49, 50]. Indeed, PMFs of these three NP
bands do not contain completely identical sets of NP
peptides. The lowest band contains peptides correspond-
ing to P protein and their presence could possibly sup-
press some NP peptides. Nevertheless, when molecular
masses of these NP proteins are calculated from se-
quences covered by the MS detected peptides, these data
are in line with the experimentally obtained apparent
molecular masses of NP bands. For the lowest NP band
peptides detected in the PMF spectrum showed peptide
coverage up to amino acid 400 (Fig. 3(b)). For the NP
band with apparent molecular mass of 55 kDa detected
peptide coverage ends with amino acid 525. Only for the
NP band with apparent molecular mass of 61 kDa pep-
tide from the C-terminus has been detected so this
would indicate that NP bands with lower molecular
masses are C-terminally truncated NP protein forms.
Additionally, mumps virus proteins were detected also
using anti-mumps serum in Western blot. The anti-
mumps serum recognized three protein bands between
50 and 60 kDa and these correspond to MS identified
NP forms (Additional file 1: Figure S2). Detection of
only NP by the anti-mumps serum is probably a result
of immunodominance of the NP as the most abundant
mumps protein. There are reports on two forms (66 and
61 kDa) of mumps NP (Enders strain) detected with NP-
specific monoclonal antibodies [51]. The 61 kDa form
was speculated to be a product of cell proteases activity
[51]. There is also one report on a truncated NP form
spanning amino-acid sequence 331–498, found in cells
infected with influenza virus [52]. Occurrence of this
truncated NP follows kinetics of full length NP and there
are no other NP forms detected with antibodies against
the N-terminal part of NP protein. In addition, site at
which proteolytic action should occur to result in this
truncated form is not characteristic for any known endo-
protease so this truncated form is reported as a likely re-
sult of transcription of one of the open reading frames
[52]. Another example of truncated NP is in human in-
fluenza virus where the NP was found susceptible to
cleavage by host cell caspase resulting in removal of the
N-terminal peptide, and both NP forms have been found
in infected cells and virions [53, 54]. The role of N-
terminal caspase cleavage of influenza NP correlates
with the host origin of the virus and is speculated to be
a molecular determinant for host range [55]. The source
and role of here detected NP forms that seem to be C-
terminally truncated remains to be determined. It is
known that the C-terminal part of NP in the subfamily
of Paramyxovirinae is largely unstructured varying
widely in length and sequence composition [4]. Open
reading frames can result in alternate NP forms but the
longest such form for mumps virus would have only 88
amino acids so this option is excluded. Other possibil-
ities are editing of transcripts by RNA polymerase or hy-
drolysis by some cell protease.
M protein was detected in two very closely neighbour-
ing gel bands under non-reducing conditions around
40 kDa corresponding nicely to the theoretical molecular
mass of M protein. One band of a slightly higher appar-
ent molecular mass was detected under reducing condi-
tions. MS sequence analysis of M protein-derived
peptides confirmed a protein modification, the acetyl-
ation of the N-terminus. M protein is one of the three
most intensive proteins of mumps virus detected under
experimental conditions used here, in addition to HN
and NP, which is expected since it is a structural protein
linking nucleocapsid to the lipid envelope.
According to literature HN protein is a disulphide
bonded oligomer [2], thought to form tetramers as a ma-
ture protein [56–58] and was detected as dimer [32] and
dimer and tetramer in addition to monomer form [31]
in purified mumps virus samples. Here, HN protein was
identified in two protein bands (around 70 and 160 kDa)
that roughly correspond to theoretical monomer and
dimer forms of HN taking into consideration that the
molecular mass of HN calculated from amino-acid se-
quence is 64 kDa and that HN is glycosylated resulting
in higher molecular mass. Electrophoresis under redu-
cing conditions resulted in more intensive gel bands for
the monomer in comparison to non-reducing conditions
(Fig. 1) but the dimer did not disappear completely.
These results indicate that in mumps virus particle a
part of HN is present as a monomer and part as a disul-
phide bridged dimer.
In addition to P protein that was detected in protein
band together with smallest NP form (in both CEF and
Vero samples), L protein was also detected (in Vero
samples), both at apparent molecular masses corre-
sponding to the theoretical ones. V protein was also de-
tected (in Vero samples) but as a faint band. V protein
has not been shown as a part of mumps virion so far but
this could be a result of limitation of the techniques
used, it was only detected in cell lysate [30].
Mumps virus lipids
Lipid classes present in two mumps virus strains, L-Zg
and Jeryl Lynn 5 (JL5), grown in two cell lines, CEF and
Vero, were analysed as well as lipids present in non-
infected cells. Lipids were isolated by organic extraction,
separated by two-dimensional high-performance thin
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layer chromatography (2D-HPTLC), visualised by pri-
muline staining, extracted from the excised chromato-
graphic plate material and analysed by MALDI MS. This
methodology is relatively straightforward and provides
wealth of data, however it is only a qualitative approach
providing a global view on present lipid classes which
does not detect lipids with masses below m/z 500.
Representative 2D-HPTLC separations of mumps virus
lipids and lipids isolated from cells are given in Fig. 4. It
can be seen that mumps virus derived from CEF cells
has a lower number of present lipid classes compared to
viruses grown in Vero cells especially regarding glyco-
lipids. Similar results were observed for total cell lipids.
The overall lipid composition of mumps virus samples is
characterized by lipids also found for other viruses such as
phosphatidylcholine, phosphatidylethanolamine, sphingo-
myeline, phosphatidic acid, glycerophosphocholine, phos-
phatidylinositol and glycolipids [14, 15, 17–24, 59].
Interestingly, in virus samples derived from Vero cells we
detected glycolipids with up to five monosaccharide units
(the most polar compounds detected on HPTLC plates).
Representative mass spectra and PSD spectra of glyco-
lipids are given in Fig. 5. The importance of glycosylation
in virulence and immune interactions on the level of gly-
coproteins is quite well known [60–62] but the impact of
glycolipids on virus properties has not been studied yet
and their relevance could be equally important. Some re-
ports on lipidomes of other viruses did not detect any gly-
colipids [17], some detected only glycolipids with one or
two monosaccharide moieties [14, 15, 19, 20] but there
are no reports on such complex virus glycolipids as de-
tected in this study for mumps virus derived from Vero
cells. The reason for this might be the methodology ap-
plied in other studies possibly omitting the separation. Or
such glycolipids were actually absent since all reports dis-
cuss different cell lines possibly lacking these glycolipids.
Difference in glycolipid content for different types of cells
is demonstrated by our results showing that e.g. CEF do
not contain glycolipids in contrast to Vero cells. One
could presume that such complex glycolipids on the viral
surface result in significant differences during e.g. cell in-
fection and this we plan to investigate in our future work.
Fig. 4 2D-HPTLC of lipids isolated from two strains of mumps virus; L-Zg and JL5, grown in Vero and CEF cells, and total cell lipids. SM - sphingomye-
lin, PC -phosphatidylocholine, PC* - phosphaditylcholine one chain, PGCer - pentaglycoceramide, TTGCer - tetraglycoceramid, TGCer - triglycoceramide,
DGCer - diglycoceramide, Gcer - glycoceramide, PA - phosphatic acid, PE - glycerophosphoethanolamine, 2 - sphingomyelin, 3 - glycerophosphocho-
line, PG - phosphatidylglycerol, PI – phosphatidylinositol, nd - not determined. Development directions are denoted in the bottom right corner and
point of sample application by red circles
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AB
Fig. 5 a Positive ion MALDI mass spectra (reflectron mode) of most polar lipids (glycolipids) extracted from L-Zg and JL5 mumps virus (grown in
Vero cells) and Vero cells. b PSD spectra of pentaglyco and tetraglycolipids isolated from mumps virus grown on Vero cells. m/z values of parent
ions are indicated on each spectrum. Hex – hexose, HexNAc- N-acetylhexose
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Conclusions
Presented data on mumps virus lipids and proteins indi-
cate the presence of host cell proteins in mumps virions
as found for other viruses. Interestingly, three NP forms
were detected, two of which appear to be C-terminally
truncated NP proteins of yet unknown function. Lipid
analysis of mumps virus showed lipid pattern to be host
dependent and viruses derived from Vero cells were
found to contain glycolipids with up to five monosac-
charide units. Presented results demonstrate virus vari-
ability and impact of these differences on virus
characteristics remains to be determined.
Methods
Cell lines and viruses
Vero cells (African green monkey kidney cells) were pur-
chased from ATCC and maintained in Minimum Essen-
tial Medium with Hank’s salts (MEM-H) (AppliChem)
supplemented with 10 % foetal calf serum (FCS) (More-
gate) and 50 μL/mL neomycin (Gibco-Life Technolo-
gies). Chicken embryo fibroblasts (CEF) were prepared
from the 11-day old embryonated chicken eggs as de-
scribed [63]. L-Zg mumps virus strain was obtained
from the Institute of Immunology Inc., Zagreb, Croatia.
The virus strain JL5 was kindly provided by B. K. Rima
(Queen's University of Belfast, United Kingdom).
Both viruses, L-Zg and JL5, were grown in Vero cells
and CEFs in MEM-(H) with 2 % FCS at m.o.i. 0.0001.
After 24 h the medium was replaced with medium with-
out serum and virus was further grown until the cyto-
pathic effect was observed. Then the medium was
collected and centrifuged at 3000 × g to remove large-
sized contaminants, and after that viruses were ultracen-
trifuged at 142,000 × g for 2 h and the pellet was resus-
pended in phosphate-buffered saline.
Protein analysis
Electrophoresis under denaturating conditions was per-
formed using 8 cm 4–12 % Bis-Tris precast gels, using
MES running buffer and Novex Sharp Standard, in an
XCell Sure Lock system from Invitrogen (Carlsbad) ac-
cording to manufacturer’s instructions. Western blot de-
tection was performed using guinea pig serum against
mumps virus which was cultured in Vero cells and puri-
fied by ultracentrifugation. ECL Prime Western Blotting
Detection Reagent was used for detection, according to
the manufacturer’s instructions (GE Healthcare). De-
tection of protein bands was performed using acidic
Coomassie Brilliant Blue R250 solution. Protein bands
were excised from the gel, trypsinized and peptides
isolated and purified for MS analysis as described
[64]. Experiments were performed with at least two
sample replicates.
Lipid analysis
Lipid isolation was performed according to Bligh and
Dyer [65]. Lipids were dried in vacuo and separated by
2D-HPTLC (silica plates, 5 × 5 cm, particle size 4–8 μm,
Merck) using chloroform/methanol/conc. ammonia
10:5:1 (V/V/V) for first dimension and after air-drying
by means of chloroform/methanol/acetic acid/water
15:3:2:0.6 (V/V/V) for second dimension. Lipids were de-
tected using primuline solution (0.05 % solution of pri-
muline in acetone/water 8:2 (V/V)) and 365 nm UV
light. Lipid spots were scratched from plates and 250 μL
of chloroform/methanol/water 10:10:0.1 (V/V/V) was
added in order to extract the lipids and extraction pro-
cedure was repeated two times. Obtained extracts were
pooled and dried in vacuo. Lipids were dissolved in 4 μL
of 20 mg/mL 2,4,6-trihydroxyacetophenone solution in
methanol and applied to a stainless steel MALDI
(matrix-assisted laser desorption/ionization) -target.
Ricinus oil (0.5 μL in 1 mL of methanol with addition of
small amount of NaCl) was used for mass calibration of
the MS instruments. Experiments were performed at
least with three separate samples.
MALDI MS analysis
Measurements were performed either on an AXIMA
TOF2 instrument (Shimadzu - Kratos Analytical) or an
UltrafleXtreme (Bruker Daltonik) in positive, reflectron
ion mode. AXIMA TOF2 is equipped with a 20 Hz nitro-
gen laser (337 nm) and was operated in the positive ion
mode applying an accelerating voltage of 20 keV. Ana-
lyses by means of an UltrafleXtreme (with a 2 kHz
SmartBeam solid state laser (355 nm)) were performed
at an acceleration voltage of 8 kV in the positive mode.
Raw data generated on AXIMA TOF2 instruments
were converted into mzXML files and processed using
mMass [66]. Data generated on UltrafleXtreme were proc-
essed using Flexanalysis (3.4.70) and Biotools (3.2_SR4).
Identification searches were performed against NCBInr
database, “other viruses”, with the following fixed parame-
ters: precursor ion mass tolerance and product ion mass
tolerance of ± 0.6 Da and ± 1.2 Da for AXIMA TOF2, ±
200 ppm and ± 200 ppm for UltrafleXtreme (respectively),
two missed trypsin cleavages, carbamidomethylation of
Cys and with variable modification: oxidation of Met, am-
monia loss from N-terminal Cys, N-acetylation, deamida-
tion, and phosphorylation. Data on lipids were analysed
using LIPID MAPS Structure Database (LMSD) [67].
Additional file
Additional file 1: Table S1. Identification of protein bands shown in
Figs. 1 & 2. Table S2. List of peptides found in spectra corresponding to
NP bands shown in Fig. 1 and possible matching NP and P peptides.
Table S3. List of peptides found in spectra corresponding to NP bands
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shown in Fig. 2 and possible matching NP and P peptides. Figure S1.
Peptide mass fingerprint by means of positive ion MALDI reflectron MS
of NP forms (depicted in Fig. 2b, reduced sample). Green (bottom)
spectrum – NP apparent molecular weight 48 kDa; blue (middle)
spectrum – NP apparent molecular weight 55 kDa; red (top) spectrum –
NP apparent molecular weight 61 kDa. Full peptide list is given in Table
S3. Figure S2. Western blot of mumps virus samples; L-Zg/Vero, JL/Vero,
JL/CEF (from left to right) subjected to electrophoresis under reducing
denaturating conditions detected by anti-mumps serum. (PDF 612 kb)
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